Global Machine Learning in Respiratory Diseases Market Research Report 2024

Publication ID:

PB508246331

Publication Date:

August 23, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

IT Services [2]

Computing & Electronics [3]

Description:

Machine learning techniques are applied to analyze vast amounts of data related to respiratory diseases (such as asthma or COPD). It helps in predictive analytics, diagnostics, treatment optimization, and disease management.
The global Machine Learning in Respiratory Diseases market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Machine Learning in Respiratory Diseases is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Machine Learning in Respiratory Diseases is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Machine Learning in Respiratory Diseases in Hospital is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Machine Learning in Respiratory Diseases include ArtiQ, Philips Healthcare, GE Healthcare, Siemens Healthineers, Swaasa AI, THIRONA, DeepMind Health, Verily and VIDA Diagnostics Inc, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Machine Learning in Respiratory Diseases, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Machine Learning in Respiratory Diseases.
Report Scope
The Machine Learning in Respiratory Diseases market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Machine Learning in Respiratory Diseases market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Machine Learning in Respiratory Diseases companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
ArtiQ
Philips Healthcare
GE Healthcare
Siemens Healthineers
Swaasa AI
THIRONA
DeepMind Health
Verily
VIDA Diagnostics Inc
Icometrix
Infervision
PneumoWave
Respiray
Dectrocel Healthcare
Zynnon
Segment by Type
Pulmonary Infection
MRI
CT Scan
Segment by Application
Hospital
Diagnostic Centers
Ambulatory Surgical Centers
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Machine Learning in Respiratory Diseases companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Machine Learning in Respiratory Diseases Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Pulmonary Infection
1.2.3 MRI
1.2.4 CT Scan
1.3 Market by Application
1.3.1 Global Machine Learning in Respiratory Diseases Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Diagnostic Centers
1.3.4 Ambulatory Surgical Centers
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Machine Learning in Respiratory Diseases Market Perspective (2019-2030)
2.2 Machine Learning in Respiratory Diseases Growth Trends by Region
2.2.1 Global Machine Learning in Respiratory Diseases Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Machine Learning in Respiratory Diseases Historic Market Size by Region (2019-2024)
2.2.3 Machine Learning in Respiratory Diseases Forecasted Market Size by Region (2025-2030)
2.3 Machine Learning in Respiratory Diseases Market Dynamics
2.3.1 Machine Learning in Respiratory Diseases Industry Trends
2.3.2 Machine Learning in Respiratory Diseases Market Drivers
2.3.3 Machine Learning in Respiratory Diseases Market Challenges
2.3.4 Machine Learning in Respiratory Diseases Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Machine Learning in Respiratory Diseases Players by Revenue
3.1.1 Global Top Machine Learning in Respiratory Diseases Players by Revenue (2019-2024)
3.1.2 Global Machine Learning in Respiratory Diseases Revenue Market Share by Players (2019-2024)
3.2 Global Machine Learning in Respiratory Diseases Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Machine Learning in Respiratory Diseases Revenue
3.4 Global Machine Learning in Respiratory Diseases Market Concentration Ratio
3.4.1 Global Machine Learning in Respiratory Diseases Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Machine Learning in Respiratory Diseases Revenue in 2023
3.5 Machine Learning in Respiratory Diseases Key Players Head office and Area Served
3.6 Key Players Machine Learning in Respiratory Diseases Product Solution and Service
3.7 Date of Enter into Machine Learning in Respiratory Diseases Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Machine Learning in Respiratory Diseases Breakdown Data by Type
4.1 Global Machine Learning in Respiratory Diseases Historic Market Size by Type (2019-2024)
4.2 Global Machine Learning in Respiratory Diseases Forecasted Market Size by Type (2025-2030)
5 Machine Learning in Respiratory Diseases Breakdown Data by Application
5.1 Global Machine Learning in Respiratory Diseases Historic Market Size by Application (2019-2024)
5.2 Global Machine Learning in Respiratory Diseases Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Machine Learning in Respiratory Diseases Market Size (2019-2030)
6.2 North America Machine Learning in Respiratory Diseases Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Machine Learning in Respiratory Diseases Market Size by Country (2019-2024)
6.4 North America Machine Learning in Respiratory Diseases Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Machine Learning in Respiratory Diseases Market Size (2019-2030)
7.2 Europe Machine Learning in Respiratory Diseases Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Machine Learning in Respiratory Diseases Market Size by Country (2019-2024)
7.4 Europe Machine Learning in Respiratory Diseases Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Machine Learning in Respiratory Diseases Market Size (2019-2030)
8.2 Asia-Pacific Machine Learning in Respiratory Diseases Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Machine Learning in Respiratory Diseases Market Size by Region (2019-2024)
8.4 Asia-Pacific Machine Learning in Respiratory Diseases Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Machine Learning in Respiratory Diseases Market Size (2019-2030)
9.2 Latin America Machine Learning in Respiratory Diseases Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Machine Learning in Respiratory Diseases Market Size by Country (2019-2024)
9.4 Latin America Machine Learning in Respiratory Diseases Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Machine Learning in Respiratory Diseases Market Size (2019-2030)
10.2 Middle East & Africa Machine Learning in Respiratory Diseases Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Machine Learning in Respiratory Diseases Market Size by Country (2019-2024)
10.4 Middle East & Africa Machine Learning in Respiratory Diseases Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 ArtiQ
11.1.1 ArtiQ Company Detail
11.1.2 ArtiQ Business Overview
11.1.3 ArtiQ Machine Learning in Respiratory Diseases Introduction
11.1.4 ArtiQ Revenue in Machine Learning in Respiratory Diseases Business (2019-2024)
11.1.5 ArtiQ Recent Development
11.2 Philips Healthcare
11.2.1 Philips Healthcare Company Detail
11.2.2 Philips Healthcare Business Overview
11.2.3 Philips Healthcare Machine Learning in Respiratory Diseases Introduction
11.2.4 Philips Healthcare Revenue in Machine Learning in Respiratory Diseases Business (2019-2024)
11.2.5 Philips Healthcare Recent Development
11.3 GE Healthcare
11.3.1 GE Healthcare Company Detail
11.3.2 GE Healthcare Business Overview
11.3.3 GE Healthcare Machine Learning in Respiratory Diseases Introduction
11.3.4 GE Healthcare Revenue in Machine Learning in Respiratory Diseases Business (2019-2024)
11.3.5 GE Healthcare Recent Development
11.4 Siemens Healthineers
11.4.1 Siemens Healthineers Company Detail
11.4.2 Siemens Healthineers Business Overview
11.4.3 Siemens Healthineers Machine Learning in Respiratory Diseases Introduction
11.4.4 Siemens Healthineers Revenue in Machine Learning in Respiratory Diseases Business (2019-2024)
11.4.5 Siemens Healthineers Recent Development
11.5 Swaasa AI
11.5.1 Swaasa AI Company Detail
11.5.2 Swaasa AI Business Overview
11.5.3 Swaasa AI Machine Learning in Respiratory Diseases Introduction
11.5.4 Swaasa AI Revenue in Machine Learning in Respiratory Diseases Business (2019-2024)
11.5.5 Swaasa AI Recent Development
11.6 THIRONA
11.6.1 THIRONA Company Detail
11.6.2 THIRONA Business Overview
11.6.3 THIRONA Machine Learning in Respiratory Diseases Introduction
11.6.4 THIRONA Revenue in Machine Learning in Respiratory Diseases Business (2019-2024)
11.6.5 THIRONA Recent Development
11.7 DeepMind Health
11.7.1 DeepMind Health Company Detail
11.7.2 DeepMind Health Business Overview
11.7.3 DeepMind Health Machine Learning in Respiratory Diseases Introduction
11.7.4 DeepMind Health Revenue in Machine Learning in Respiratory Diseases Business (2019-2024)
11.7.5 DeepMind Health Recent Development
11.8 Verily
11.8.1 Verily Company Detail
11.8.2 Verily Business Overview
11.8.3 Verily Machine Learning in Respiratory Diseases Introduction
11.8.4 Verily Revenue in Machine Learning in Respiratory Diseases Business (2019-2024)
11.8.5 Verily Recent Development
11.9 VIDA Diagnostics Inc
11.9.1 VIDA Diagnostics Inc Company Detail
11.9.2 VIDA Diagnostics Inc Business Overview
11.9.3 VIDA Diagnostics Inc Machine Learning in Respiratory Diseases Introduction
11.9.4 VIDA Diagnostics Inc Revenue in Machine Learning in Respiratory Diseases Business (2019-2024)
11.9.5 VIDA Diagnostics Inc Recent Development
11.10 Icometrix
11.10.1 Icometrix Company Detail
11.10.2 Icometrix Business Overview
11.10.3 Icometrix Machine Learning in Respiratory Diseases Introduction
11.10.4 Icometrix Revenue in Machine Learning in Respiratory Diseases Business (2019-2024)
11.10.5 Icometrix Recent Development
11.11 Infervision
11.11.1 Infervision Company Detail
11.11.2 Infervision Business Overview
11.11.3 Infervision Machine Learning in Respiratory Diseases Introduction
11.11.4 Infervision Revenue in Machine Learning in Respiratory Diseases Business (2019-2024)
11.11.5 Infervision Recent Development
11.12 PneumoWave
11.12.1 PneumoWave Company Detail
11.12.2 PneumoWave Business Overview
11.12.3 PneumoWave Machine Learning in Respiratory Diseases Introduction
11.12.4 PneumoWave Revenue in Machine Learning in Respiratory Diseases Business (2019-2024)
11.12.5 PneumoWave Recent Development
11.13 Respiray
11.13.1 Respiray Company Detail
11.13.2 Respiray Business Overview
11.13.3 Respiray Machine Learning in Respiratory Diseases Introduction
11.13.4 Respiray Revenue in Machine Learning in Respiratory Diseases Business (2019-2024)
11.13.5 Respiray Recent Development
11.14 Dectrocel Healthcare
11.14.1 Dectrocel Healthcare Company Detail
11.14.2 Dectrocel Healthcare Business Overview
11.14.3 Dectrocel Healthcare Machine Learning in Respiratory Diseases Introduction
11.14.4 Dectrocel Healthcare Revenue in Machine Learning in Respiratory Diseases Business (2019-2024)
11.14.5 Dectrocel Healthcare Recent Development
11.15 Zynnon
11.15.1 Zynnon Company Detail
11.15.2 Zynnon Business Overview
11.15.3 Zynnon Machine Learning in Respiratory Diseases Introduction
11.15.4 Zynnon Revenue in Machine Learning in Respiratory Diseases Business (2019-2024)
11.15.5 Zynnon Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Companies Mentioned:

ArtiQ
Philips Healthcare
GE Healthcare
Siemens Healthineers
Swaasa AI
THIRONA
DeepMind Health
Verily
VIDA Diagnostics Inc
Icometrix
Infervision
PneumoWave
Respiray
Dectrocel Healthcare
Zynnon

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂